May 12 (BusinessDesk) - AFT Pharmaceuticals more than tripled sales of its flagship Maxigesic tablet in the 2017 financial year and anticipates more growth as it taps new markets. The Auckland-based ...

For the above reasons, Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to provide initial guidance only and it does ...

AFT has been justified in making a series of claims in relation to the efficacy of its Maxigesic pain relief tablets.Supplied / Supplied The Australian High Court has sided with AFT Pharmaceuticals in ...

AFT Pharmaceuticals obtained regulatory approval to sell its Maxigesic painkiller in nine additional European countries, a move that lets it ramp up international sales of its tablets. The ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced ...

AFT Pharmaceuticals managing director Hartley Atkinson with wife Maree Atkinson. AFT Pharmaceuticals, which manufactures the Maxigesic painkiller, reported a full-year loss in the year to March 31 but ...

The AFP Pharmaceuticals Ltd (ASX: AFP) share price is up 3.2% today after announcing a raft of agreements and a new establishment in Europe. AFT Pharmaceuticals share price is rising today after the ...

LONDON, April 28, 2021 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces it has signed an exclusive license and distribution agreement with AFT ...

The White House and congressional officials have been scrutinizing Apple's plan to strike a deal with Alibaba to make the Chinese company's AI available on iPhones in China, The New York Times ...